Mapping large numbers of results may take a few moments.
Search Results
Showing 101 - 150 of 581 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company BioIVT | Activity: Research and Development | Company Description BioIVT provides biological specimens, specializing in control and disease state human and animal tissues. This site develops and commercializes cell-based drug toxicity-testing products for pharmaceutical development, based on hepatocyte technologies. | Location Durham | |
Company BioKier Inc. | Activity: Research and Development | Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. | Location Chapel Hill | |
Company BioLink Life Sciences Inc. | Activity: Contract Research and Testing | Company Description BioLink provides contract product development support through custom synthesis and testing for the pharmaceutical, nutraceuticals, animal health and chemical industries. | Location Cary | |
Company Biological Applied Research Inc. | Activity: Contract Research and Testing | Company Description Biological Applied Research provides product efficacy testing of agricultural chemicals such as fungicides and nematicides on various crops, including fruit and vegetables. | Location Raleigh | |
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville | |
Company BIOMILQ | Activity: Research and Development | Company Description BIOMILQ is a women-owned biotechnology start-up leveraging patented technology to produce functional human milk components for early-life nutrition products through cell culture technology. | Location Durham | |
Company bioMONTR Labs | Activity: Contract Research and Testing | Company Description bioMONTR provides a broad range of CLIA-certified high-complexity laboratory testing, including assay/IVD protocol development, validation design, performance evaluation testing, drug trials and collaborative studies and regulatory/quality control. | Location Cary | |
Company Bionpharma Inc. | Activity: Sales and Operations | Company Description Bionpharma partners with pharmaceutical companies to in-license, out-license, develop, manufacture and distribute generic and over-the-counter products. Its Raleigh location is a sales office. | Location Morrisville | |
Company Biorbyt (Raleigh) | Activity: Sales and Operations | Company Description Biorbyt sells antibodies, proteins, small molecules and biochemical tools for life sciences research. | Location Raleigh | |
Company BioResource International Inc. | Activity: Research and Development | Company Description BioResource International (BRI) designs, develops and manufactures unique enzymes that help poultry and swine producers optimize animal nutrition and gut health. | Location Durham | |
Company BioRxn LLC | Activity: Research and Development | Company Description BioRxn develops NMR-based metabolomic technology, including bioreactor and artificial liver systems, for non-invasive monitoring of metabolic biomarkers. BioRxn also provides conventional metabolomic services. | Location Chapel Hill | |
Company BioSkryb Corp. | Activity: Research and Development | Company Description BioSkryb's SkrybAmp technology is a new DNA amplification technology powered by Primary Template Directed Amplification (PTA). | Location Durham | |
Company Biotalys Inc. | Activity: Sales and Operations | Company Description Biotalys uses its proprietary technology platform to develop protein-based biocontrol solutions as alternatives to crop protection chemicals. | Location Raleigh | |
Company BioTek Ag LLC | Activity: Production and Manufacturing | Company Description BioTek Ag produces plant growth regulators, nutritional products, surfactants and other specialty products to enhance soil biology and crop input effectiveness. | Location Clinton | |
Company Biovet S.A. | Activity: Sales and Operations | Company Description Biovet develops nutritional supplements, enzymes, pronutrients, digestives, antioxidants, preservatives, mycotoxin binders and flavoring for feed for poultry, ruminants, swine and aquaculture. | Location Durham | |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest | |
Company Bloodless Dx LLC | Activity: Research and Development | Company Description Bloodless Dx is an assay development company focused on bloodless diagnostics. | Location Apex | |
Company BMPolytech LLC | Activity: Research and Development | Company Description BMPolytech is developing a new class of synthetic materials, tissue-mimetic Brush-like Polymer Networks, for use in advanced biomedical devices, such as implants, drug delivery devices and wound care. | Location Chapel Hill | |
Company Boundless Science LLC | Activity: Research and Development | Company Description Boundless Science develops a device for heart and lung oxygenation as a safer alternative to ECMO. | Location Chapel Hill | |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh | |
Company Brighton Development LLC | Activity: Research and Development | Company Description Brighton Development develops sterilizing technologies and antimicrobial medical plastics. | Location Cary | |
Company Brightseed (Durham) | Activity: Research and Development | Company Description Brightseed developed an AI-driven discovery platform, Forager, to identify plant bioactives as potential therapeutic solutions. | Location Durham | |
Company Brii Biosciences Inc. | Activity: Research and Development | Company Description Brii Biosciences develops therapies focused on infectious diseases and central nervous system diseases where patients experience high levels of unmet medical needs, limited choice and significant social stigmas. | Location Durham | |
Company Bryn Pharma LLC | Activity: Research and Development | Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. | Location Raleigh | |
Company Burleson Research Technologies Inc. | Activity: Contract Research and Testing | Company Description Burleson Research Technologies provides laboratory services to the biotechnology, pharmaceutical, chemical manufacturing and health care industries with proof-of-concept, preclinical, clinical and toxicology studies. | Location Morrisville | |
Company Caeregen Therapeutics LLC | Activity: Research and Development | Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. | Location Chapel Hill | |
Company Caidya | Activity: Contract Research and Testing | Company Description Caidya provides full global CRO service to pharmaceutical and biotechnology companies, working across all major therapeutic areas including oncology, gastroenterology and women's health and rare disease. | Location Morrisville | |
Company Campbell University Pharmaceutical Education and Research Center (PERC) | Activity: Contract Research and Testing | Company Description The Pharmaceutical Education & Research Center (PERC) offers analytical, formulation, R&D, clinical manufacturing and training services to the pharma and biotech industries, compounding pharmacies, government agencies and other academic institutions. | Location Buies Creek | |
Company Cancer Advances Inc. | Activity: Research and Development | Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. | Location Durham | |
Company CardioPharma Inc. | Activity: Research and Development | Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. | Location Wilmington | |
Company CARsgen Therapeutics | Activity: Production and Manufacturing | Company Description CARsgen Therapeutics develops innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors. | Location Durham | |
Company CasTag Biosciences Inc. | Activity: Production and Manufacturing | Company Description CasTag Biosciences provides custom AAV kits. It uses CRISPR knock-in technology to produce genome-wide arrayed libraries with a variety of donors for endogenous protein analysis in cells and tissue. | Location Durham | |
Company Cell Microsystems Inc. | Activity: Research and Development | Company Description Cell Microsystems develops, manufactures, and markets products for single cell workflows including CRISPR gene editing, stem cell research, organoid studies, cell line development and antibody discovery. | Location Durham | |
Company Cell Spinpod LLC | Activity: Research and Development | Company Description Cell Spinpod develops and sells rotating suspension cell culture devices. Cell spinpods are miniature rotating bioreactors that keep cells, spheroids, or microorganisms in 3D suspension culture. | Location Chapel Hill | |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh | |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill | |
Company Cellex Inc. | Activity: Research and Development | Company Description Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use. | Location Cary | |
Company Celplor LLC | Activity: Contract Research and Testing | Company Description Celplor provides molecular biology services, including stable cell line generation, Southern blot analysis, Western blot analysis, cDNA cloning and mouse tail genotyping. | Location Cary | |
Company Cerulean Scientific | Activity: Research and Development | Company Description Cerulean Scientific has developed an omniphobic coating for implantable medical devices to resist pathogen colonization and thrombosis. Cerulean develops products using the coating for neurosurgical and vascular surgical applications. | Location Durham | |
Company Cervu Health | Activity: Research and Development | Company Description Cervu is developing an intravaginal pelvic floor physical therapy tool to help female cancer survivors manage chronic pelvic pain and dyspareunia (pain with sexual intercourse). | Location Cary | |
Company Cessation Therapeutics | Activity: Sales and Operations | Company Description Cessation Therapeutics is developing novel antibody therapies to prevent and reverse overdose related to fentanyl and related synthetic opioids. The Chapel Hill site is Cessation's corporate office. | Location Chapel Hill | |
Company Chemistry Center for Combatting Antibiotic Resistant Bacteria (CC4CARB) | Activity: Contract Research and Testing | Company Description The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB) is a NIH NIAID led initiative contracted with RTI International. CC4CARB is a free service focused on the synthesis and delivery of libraries for use in Gram-negative antibacterial drug discovery programs. | Location Research Triangle Park | |
Company ChemoGenics Biopharma LLC | Activity: Contract Research and Testing | Company Description ChemoGenics BioPharma provides collaborative drug discovery, bioanalytical, formulation and scale-up services. Capabilities include medicinal chemistry, DMPK, bioinformatics and preclinical models in cancer, inflammation and metabolic diseases. | Location Durham | |
Company ChemQ Bioscience LLC | Activity: Production and Manufacturing | Company Description ChemQ Bioscience develops and markets novel liquid products, such as bio-preservation media, tissue perfusion solutions and liquid-based cytology processing kits. ChemQ also offers contract research services and custom formulation. | Location Research Triangle Park | |
Company Chesson Laboratory Associates Inc. | Activity: Research and Development | Company Description Chesson Labs develops prescription and over-the-counter polymer-based medical products for wound care and skin and nail care products. | Location Durham | |
Company Chimerix Inc. | Activity: Research and Development | Company Description Chimerix discovers, develops and commercializes broad spectrum antivirals for the prevention and treatment of life-threatening viral infections. | Location Durham | |
Company Citranvi Biosciences LLC | Activity: Research and Development | Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. | Location Chapel Hill | |
Company CivaTech Oncology Inc. | Activity: Research and Development | Company Description CivaTech Oncology has developed targeted implantable radiation devices to treat many cancer types. Products provide a targeted, customized radiation dose during a surgical resection procedure or in outpatient therapies to treat cancers. | Location Morrisville | |
Company CiVentiChem USA LLC | Activity: Sales and Operations | Company Description CiVentiChem provides contract R&D and manufacturing services, including process development work and manufacturing of intermediates and Regulatory Starting Materials (RSM). | Location Cary | |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham |